These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11895041)

  • 1. The pathology of the spinal cord in progressive supranuclear palsy.
    Vitaliani R; Scaravilli T; Egarter-Vigl E; Giometto B; Klein C; Scaravilli F; An SF; Pramstaller PP
    J Neuropathol Exp Neurol; 2002 Mar; 61(3):268-74. PubMed ID: 11895041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widespread spinal cord involvement in progressive supranuclear palsy.
    Iwasaki Y; Yoshida M; Hashizume Y; Hattori M; Aiba I; Sobue G
    Neuropathology; 2007 Aug; 27(4):331-40. PubMed ID: 17899686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical, ultrastructural and immunoelectron microscopic studies of spinal cord neurofibrillary tangles in progressive supranuclear palsy.
    Kato S; Hirano A; Llena JF
    Neuropathol Appl Neurobiol; 1992 Dec; 18(6):531-8. PubMed ID: 1488085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibrillary tangles in the neurons of spinal dorsal root ganglia of patients with progressive supranuclear palsy.
    Nishimura M; Namba Y; Ikeda K; Akiguchi I; Oda M
    Acta Neuropathol; 1993; 85(5):453-7. PubMed ID: 8388145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease.
    Li F; Iseki E; Odawara T; Kosaka K; Yagishita S; Amano N
    J Neurol Sci; 1998 Jul; 159(1):73-81. PubMed ID: 9700707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histopathological and immunohistochemical study of spinal cord tissues in neurodegenerative diseases].
    Zhu M; Wang L; Liu J; Gui Q; Guo Y; Hu Y; Zhang H
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):587-93. PubMed ID: 26705184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal loss in Onuf's nucleus in three patients with progressive supranuclear palsy.
    Scaravilli T; Pramstaller PP; Salerno A; Egarter-Vigl E; Giometto B; Vitaliani R; An SF; Revesz T
    Ann Neurol; 2000 Jul; 48(1):97-101. PubMed ID: 10894221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial patterns of the tau pathology in progressive supranuclear palsy.
    Armstrong RA; Cairns NJ
    Neurol Sci; 2013 Mar; 34(3):337-44. PubMed ID: 22411688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
    Togo T; Dickson DW
    Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential neurodegeneration in the cervical spinal cord of progressive supranuclear palsy.
    Kikuchi H; Doh-ura K; Kira J; Iwaki T
    Acta Neuropathol; 1999 Jun; 97(6):577-84. PubMed ID: 10378376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laminar distribution of the pathological changes in frontal and temporal cortex in 8 patients with progressive supranuclear palsy.
    Armstrong RA; Cairns NJ
    Clin Neuropathol; 2009; 28(5):350-7. PubMed ID: 19788050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
    Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibrillary pathology in progressive supranuclear palsy (PSP).
    Cervós-Navarro J; Schumacher K
    J Neural Transm Suppl; 1994; 42():153-64. PubMed ID: 7964685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between neuronal loss and tangle formation in neurons and oligodendroglia in progressive supranuclear palsy.
    Jin C; Katayama S; Hiji M; Watanabe C; Noda K; Nakamura S; Matsumoto M
    Neuropathology; 2006 Feb; 26(1):50-6. PubMed ID: 16521479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
    Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
    Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of a case with progressive supranuclear palsy without ophthalmoplegia.
    Kida E; Barcikowska M; Niemczewska M
    Acta Neuropathol; 1992; 83(3):328-32. PubMed ID: 1557959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy.
    Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T
    Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant accumulation of ErbB4 in progressive supranuclear palsy.
    Murakami A; Nakamura M; Kaneko S; Lin WL; Dickson DW; Kusaka H
    Neuropathol Appl Neurobiol; 2018 Oct; 44(6):563-573. PubMed ID: 29319907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.